市场调查报告书
商品编码
1519344
2024-2032 年按产品类型、程序、应用、最终用户和地区分類的脑监测市场报告Brain Monitoring Market Report by Product Type, Procedure, Application, End User, and Region 2024-2032 |
2023年,全球脑监测市场规模达到64亿美元。神经系统疾病发病率的增加、大脑监测设备的技术进步、对大脑健康的日益关注以及人口老化是市场成长的主要推动力。
主要市场驱动因素:神经退化性疾病在大众中的盛行率不断上升,加上老年人口的不断增加,正在刺激市场成长。此外,随着无线技术的出现、技术的不断进步和医疗设备的小型化,各种脑部监测设备的尺寸已大大减小,这反过来又导致了这些设备的更广泛采用。
主要市场趋势:对非侵入性和微创手术的需求不断增长,推动了市场成长。除此之外,医疗保健基础设施的持续发展以及主要参与者进行的广泛研发(R&D)活动正在不断增加市场需求。
竞争格局:市场上一些知名的公司包括 Advanced Brain Monitoring Inc.、Cadwell Industries Inc.、Compumedics Limited (D & DJ Burton Holdings Pty Ltd.)、Dragerwerk AG & Co. KGaA、Elekta、通用电气公司、Integra LifeSciences、 Koninklijke Philips NV、Masimo、Medtronic plc、Natus Medical Incorporated、Nihon Kohden Corporation、Siemens Healthineers AG (Siemens AG) 和Spiegelberg GmbH & Co. KG. 等。
地理趋势:北美地区受益于神经病学和神经科学领域的广泛研究和开发活动,为大脑监测设备的技术进步做出了贡献。此外,欧洲国家拥有完善的医疗体系、强大的研究能力和优惠的报销政策,这些都促进了市场的成长。除此之外,快速的经济成长和不断改善的医疗基础设施也促进了亚太市场的成长。
挑战与机会:技术成本高、监管障碍以及隐私和道德问题是市场面临的一些挑战。然而,神经影像技术、人工智慧和机器学习的不断进步为开发更准确、更有效率的大脑监测设备提供了机会。
神经系统疾病盛行率上升
神经系统疾病盛行率的上升是影响大脑监测市场成长的重要因素。随着世界各地人口老化,阿兹海默症和帕金森氏症等与年龄相关的神经系统疾病的发生率不断增加。例如,根据美国国家医学图书馆发表的一篇文章,人口老化显着增加了各种神经系统疾病的社会负担,包括阿兹海默症、原发性恶性脑瘤、帕金森氏症和肌肉萎缩侧索硬化症。此外,根据世界卫生组织 (WHO) 的数据,60 岁及以上的成年人中有近 14% 患有精神障碍。除此之外,随着神经系统疾病变得越来越普遍,越来越需要先进的诊断工具来准确检测和监测这些疾病。 EEG(脑电图)、MRI(磁振造影)和 PET(正子断层扫描)扫描等脑部监测技术在神经系统疾病的诊断和评估中发挥着至关重要的作用。例如,2024年4月,非侵入性脑刺激和协同监测技术提供者Soterix Medical Inc.推出了MxN-GO EEG,这是一款具有独特无束缚设计的高清经颅电刺激(HD-tES)和脑电图系统。该技术专为需要电刺激和监测移动和自然环境中大脑活动的研究应用而设计。这些因素进一步促进了市场成长。
脑电图 (EEG) 的应用不断增加
脑电图(EEG)应用的不断增加极大地推动了大脑监测市场的成长。脑电图对于诊断各种神经系统疾病(例如癫痫、睡眠障碍和脑肿瘤)至关重要。它检测大脑异常电活动的能力有助于准确诊断、指导治疗决策和改善患者治疗结果。例如,2022 年 7 月,美国国立卫生研究院对美国医院进行了一项调查,发现使用脑电图设备极大地改善了医生对癫痫发作的电图诊断。与临床诊断相比,电图癫痫诊断的敏感度从 77.8% 提高到 100%,特异性从 63.9% 提高到 89%。脑电图技术的不断进步,如高密度脑电图、可携式设备和改进的讯号处理技术,增强了其诊断能力和可用性。例如,2024 年 4 月,NeuroVigil 在美国推出了 iBrain 个人大脑监视器,这是一种正在研究的便携式设备,可以非侵入性地记录患有神经系统问题的人的电活动。 iBrain 是基于脑电图 (EEG) 技术,该技术通常用于评估脑电活动和检测神经异常。患者可以在家中和睡眠期间使用该小工具更有效、更轻鬆地获取脑电图资料。这些技术改进使脑电图在不同的医疗保健环境中更容易获得和可靠,从而促进更广泛的采用和市场扩张。这些因素进一步提高了大脑监测市场占有率。
新兴神经科学研究
不断增加的神经科学研究正在促进大脑监测市场的成长。神经科学研究不断突破大脑影像技术的界限,例如 MRI(磁振造影)、PET(正子断层扫描)、CT(电脑断层扫描)和 EEG(脑电图)。例如,2024 年 5 月,GE HealthCare 推出了 SIGNA MAGNUS,这是一款尖端的头部磁振造影 (MRI) 扫描仪。 SIGNA MAGNUS 是一项重大进步,为科学家提供了深入检查大脑复杂性的强大工具。这些技术对于可视化和理解健康个体和患有神经系统疾病的人的大脑结构、功能和连接性至关重要。除此之外,神经科学研究也越来越多地利用人工智慧和机器学习演算法来分析大规模脑部造影和脑电图资料。这些先进的分析工具增强了对复杂大脑活动模式的解释,识别微妙的生物标记物,并预测疾病进展。此外,各种组织正在促进人工智慧在脑部疾病中的应用,以提供更好的诊断。例如,2024年2月,独立非营利组织万脑计画启动,旨在促进人工智慧(AI)在对抗阿兹海默症、帕金森氏症和其他神经系统疾病方面的道德应用。该组织的目标是提供所需的领导力、经验和财务援助,以确保研究人员能够快速采用这项强大的新技术,为有需要的患者提供更好的诊断和治疗。这些因素都进一步加剧了市场需求。
The global brain monitoring market size reached US$ 6.4 Billion in 2023. Looking forward, the market is expected to reach US$ 10.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032. Growing incidences of neurological disorders, technological advancements in brain monitoring devices, surging focus on brain health, and aging population are primarily driving the market growth.
Major Market Drivers: The increasing prevalence of neurodegenerative diseases among the masses coupled with the rising geriatric population is stimulating the market growth. Moreover, with the advent of wireless technology, continual technological advancements and the miniaturization of medical devices, the size of various brain monitoring devices has been greatly reduced, which, in turn, is resulting in the greater adoption of these devices.
Key Market Trends: The rising demand for non-invasive and minimally invasive procedures is providing an impetus to the market growth. Apart from this, continual developments in the healthcare infrastructure and extensive research and development (R&D) activities conducted by key players are escalating the market demand.
Competitive Landscape: Some of the prominent companies in the market include Advanced Brain Monitoring Inc., Cadwell Industries Inc., Compumedics Limited (D & DJ Burton Holdings Pty Ltd.), Dragerwerk AG & Co. KGaA, Elekta, General Electric Company, Integra LifeSciences, Koninklijke Philips N.V., Masimo, Medtronic plc, Natus Medical Incorporated, Nihon Kohden Corporation, Siemens Healthineers AG (Siemens AG), and Spiegelberg GmbH & Co. KG., among many others.
Geographical Trends: The North America region benefits from extensive research and development activities in neurology and neuroscience, contributing to technological advancements in brain monitoring devices. Moreover, European countries have well-established healthcare systems, robust research capabilities, and favorable reimbursement policies, which foster the market growth. Apart from this, rapid economic growth and improving healthcare infrastructure contribute to the Asia Pacific market growth.
Challenges and Opportunities: The high cost of technology, regulatory hurdles, and privacy and ethical concerns are some of the challenges that the market is facing. However, continuous advancements in neuroimaging technologies, AI, and machine learning present opportunities for developing more accurate and efficient brain monitoring devices.
Rising Prevalence of Neurological Disorders
The rising prevalence of neurological disorders is a significant factor influencing the growth of the brain monitoring market. As populations around the world age, the incidence of age-related neurological disorders such as Alzheimer's disease and Parkinson's disease increases. For instance, according to an article published by the National Library of Medicine, the aging population has significantly increased the societal burden of various neurologic illnesses, including Alzheimer's disease, primary malignant brain tumors, Parkinson's disease, and amyotrophic lateral sclerosis. Moreover, according to the World Health Organization (WHO), nearly 14% of adults aged 60 and above live with a mental disorder. Apart from this, as neurological disorders become more prevalent, there is a growing need for advanced diagnostic tools to accurately detect and monitor these conditions. Brain monitoring technologies such as EEG (electroencephalography), MRI (magnetic resonance imaging), and PET (positron emission tomography) scans play a crucial role in the diagnosis and assessment of neurological disorders. For instance, in April 2024, Soterix Medical Inc., a non-invasive brain stimulation and synergistic monitoring technologies provider, launched MxN-GO EEG, a high-definition transcranial Electrical Stimulation (HD-tES) and EEG system with a unique untethered design. The technology is designed for research applications that need electrical stimulation and monitoring of brain activity in mobile and natural settings. These factors are further proliferating the market growth.
Increasing Application of Electroencephalography (EEG)
The increasing application of Electroencephalography (EEG) is significantly driving the growth in the brain monitoring market. EEG is essential for diagnosing various neurological disorders such as epilepsy, sleep disorders, and brain tumors. Its ability to detect abnormal electrical activity in the brain helps in accurate diagnosis, guiding treatment decisions and improving patient outcomes. For instance, in July 2022, the National Institute of Health performed a survey of hospitals in the United States and discovered that using EEG equipment dramatically improved electrographic seizure diagnosis by physicians. The sensitivity of electrographic seizure diagnosis increased from 77.8% to 100%, while the specificity increased from 63.9% to 89% when compared to clinical diagnosis. Continuous advancements in EEG technology, such as high-density EEG, portable devices, and improved signal processing techniques, enhance its diagnostic capabilities and usability. For instance, in April 2024, NeuroVigil introduced the iBrain personal brain monitor in the United States, which is an investigational portable gadget that can non-invasively record electrical activity in persons with neurological problems. iBrain is based on electroencephalogram (EEG) technology, which is routinely used to assess brain electrical activity and detect neurological abnormalities. Patients can use the gadget at home and during sleep to acquire EEG data more efficiently and easily. These technological improvements make EEG more accessible and reliable across diverse healthcare settings, fostering broader adoption and market expansion. These factors are further contributing to the brain monitoring market share.
Emerging Neuroscience Research
Increasing neuroscience research is contributing to the growth of the brain monitoring market. Research in neuroscience continually pushes the boundaries of brain imaging technologies such as MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), CT (Computed Tomography), and EEG (Electroencephalography). For instance, in May 2024, GE HealthCare unveiled SIGNA MAGNUS, a cutting-edge head-only magnetic resonance imaging (MRI) scanner. SIGNA MAGNUS is a major advancement that gives scientists a strong instrument to examine the intricacies of the brain in depth. These technologies are crucial for visualizing and understanding brain structure, function, and connectivity in both healthy individuals and those with neurological disorders. Besides this, neuroscience research increasingly leverages AI and machine learning algorithms to analyze large-scale brain imaging and EEG data. These advanced analytical tools enhance the interpretation of complex brain activity patterns, identify subtle biomarkers, and predict disease progression. Also, various organizations are promoting applications of artificial intelligence in brain illnesses in order to provide better diagnostics. For instance, in February 2024, the 10,000 Brains Project, an independent non-profit organization, was launched to promote the ethical application of artificial intelligence (AI) in the battle against Alzheimer's, Parkinson's, and other neurological illnesses. The organization's aim is to provide the leadership, experience, and financial assistance required to ensure that researchers can quickly adopt this powerful new technology in the pursuit of better diagnostics and treatments for patients in need. These factors are further escalating the market demand.
IMARC Group provides an analysis of the key trends in each segment of the global brain monitoring market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, procedure, application, and end user.
Electroencephalography (EEG) Devices
Magnetoencephalography (MEG) Devices
Transcranial Doppler (TCD) Devices
Intracranial Pressure (ICP) Monitors
Cerebral Oximeters
Magnetic Resonance Imaging (MRI) Devices
Computerized Tomography (CT) Devices
Positron Emission Tomography (PET) Devices
Sleep Monitoring Devices
Electromyography (EMG) Devices
Accessories
The report has provided a detailed breakup and analysis of the market based on the product type. This includes Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, Transcranial Doppler (TCD) Devices, Intracranial Pressure (ICP) Monitors, Cerebral Oximeters, Magnetic Resonance Imaging (MRI) Devices, Computerized Tomography (CT) Devices, Positron Emission Tomography (PET) Devices, Sleep Monitoring Devices, Electromyography (EMG) Devices, and Accessories.
The demand for electroencephalography (EEG) devices is driven by the surging prevalence of epilepsy and sleep disorders. Moreover, magnetoencephalography (MEG) devices are essential for pre-surgical localization of epileptic foci and brain tumor mapping. Apart from this, the increasing incidence of stroke requiring monitoring of cerebral blood flow is bolstering the demand for transcranial doppler devices. Besides this, the demand for intracranial pressure monitors is driven by the rising cases of traumatic brain injury.
Invasive
Non-invasive
A detailed breakup and analysis of the market based on the procedure has also been provided in the report. This includes invasive and non-invasive.
High demand in intensive care units (ICUs) for monitoring patients with traumatic brain injury, intracranial hemorrhage, and hydrocephalus is driving the demand for invasive procedures. This procedure is essential for optimizing management during neurosurgical procedures such as tumor resection or placement of shunts. Non-invasive procedures are widely used for diagnosing epilepsy and sleep disorders, and monitoring brain function in stroke, coma, and neurodegenerative diseases. Moreover, it is also utilized in neuroscience research due to accessibility and real-time monitoring capabilities.
Parkinson's Disease
Traumatic Brain Injury (TBI)
Epilepsy
Dementia
Sleep Disorders
Others
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes Parkinson's disease, traumatic brain injury (TBI), epilepsy, dementia, sleep disorders, and others.
According to the brain monitoring market overview, the demand for brain monitoring technologies in the context of specific neurological conditions such as Parkinson's disease, traumatic brain injury (TBI), epilepsy, dementia, and sleep disorders is driven by various clinical needs, advancements in technology, and research initiatives. In Parkinson's disease, there is a high demand for invasive brain monitoring techniques like intraoperative microelectrode recording (MER) and intraoperative macrostimulation (IOM). Moreover, in traumatic brain injury, intracranial pressure (ICP) monitoring is essential to manage elevated ICP levels, which can lead to secondary brain injury post-TBI, guiding treatment strategies, and improving patient outcomes.
Hospitals
Diagnostic Centers
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals and diagnostic centers.
According to the brain monitoring market analysis, hospitals use brain monitoring technologies such as CT scans and MRI to quickly diagnose and assess stroke patients. These imaging modalities help determine the type of stroke (ischemic or hemorrhagic) and guide immediate treatment decisions. While neurodiagnostic centers utilize a range of brain monitoring technologies to conduct comprehensive evaluations for patients with complex neurological symptoms. This includes EEG for seizure monitoring, MEG for functional brain mapping, and PET scans for assessing metabolic activity in the brain.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
High adoption of advanced neuroimaging in United States and Canada, technologies such as MRI, CT, and PET scans in hospitals and diagnostic centers are driving the growth in North America region. Moreover, the growth in Europe is driven by a strong focus on neuroscience research, utilizing functional imaging and EEG for understanding brain function and disorders. Apart from this, the rapidly expanding healthcare infrastructure in Asia Pacific with the increasing availability of MRI and CT scans is driving the market growth in the region.
Advanced Brain Monitoring Inc.
Cadwell Industries Inc.
Compumedics Limited (D & DJ Burton Holdings Pty Ltd.)
Dragerwerk AG & Co. KGaA
Elekta
General Electric Company
Integra LifeSciences
Koninklijke Philips N.V.
Masimo
Medtronic plc
Natus Medical Incorporated
Nihon Kohden Corporation
Siemens Healthineers AG (Siemens AG)
Spiegelberg GmbH & Co. KG.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
June 2024: Hallmarq Veterinary Imaging, a developer of animal diagnostic imaging, installed the first zero-helium small animal 1.5T MRI equipment in the United States.
May 2024: GE HealthCare unveiled SIGNA MAGNUS, a cutting-edge head-only magnetic resonance imaging (MRI) scanner.
May 2024: Neurable raised US$ 13 Million to support its one-of-a-kind, non-invasive brain-computer interface (BCI) technology.